10 April 2026 | The 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐔𝐩𝐝𝐚𝐭𝐞 𝐒𝐞𝐫𝐢𝐞𝐬 𝐢𝐧 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐍𝐨.𝟏𝟎/𝟐𝟎𝟐𝟔 was successfully held earlier this morning, featuring engaging knowledge sharing presentations by two of UMBI’s Research Fellows.

𝐃𝐫. 𝐓𝐚𝐧 𝐒𝐡𝐢𝐧𝐠 𝐂𝐡𝐞𝐧𝐠 presented on 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬 𝐨𝐟 𝐜𝐚𝐧𝐜𝐞𝐫, highlighting their clinical significance in diagnosis, prognosis, and treatment guidance, while addressing current limitations and the need for more sensitive, specific, and minimally invasive approaches.

𝐓𝐬. 𝐃𝐫. 𝐒𝐚𝐢𝐟𝐮𝐥 𝐄𝐟𝐟𝐞𝐧𝐝𝐢 𝐒𝐲𝐚𝐟𝐫𝐮𝐝𝐝𝐢𝐧 shared insights on 𝐜𝐥𝐞𝐚𝐫 𝐜𝐞𝐥𝐥 𝐫𝐞𝐧𝐚𝐥 𝐜𝐞𝐥𝐥 𝐜𝐚𝐫𝐜𝐢𝐧𝐨𝐦𝐚 (𝐜𝐜𝐑𝐂𝐂), focusing on glucocorticoid receptor (GR) signaling and its role in driving oncogenic transcriptional programs. The session underscored key molecular targets and the application of advanced tools such as CRISPR-based approaches in validating these pathways.

The session concluded with an engaging Q&A, reflecting the strong interest and active participation of attendees. Thank you to all participants for your active engagement and continued support!